H

Healius Ltd
ASX:HLS

Watchlist Manager
Healius Ltd
ASX:HLS
Watchlist
Price: 1.37 AUD -1.79% Market Closed
Market Cap: 994.8m AUD
Have any thoughts about
Healius Ltd?
Write Note

Healius Ltd
Investor Relations

Healius Ltd. engages in the provision of healthcare technology solutions. The company is headquartered in Sydney, New South Wales and currently employs 11,000 full-time employees. The firm operates through three segments: Pathology, Imaging and Day Hospitals. Pathology segment provides pathology services. Imaging segment offers imaging and scanning services from imaging sites, hospitals and from within the consolidated entity's medical centers. Day Hospitals segment is an operator of day hospitals and hematology or oncology services and provides services and facilities to In-Vitro Fertilization (IVF) specialists. The firm also provides facilities and support services to general practitioners, radiologists and a range of other healthcare professionals, enabling them to care their patients in partnership with the Company's pathologists, nurses and other employees.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. Paul D. Anderson B.Com., C.A.
MD, CEO & Director
No Bio Available
Mr. Stephen Humphries B.Sc.
CFO& Company Secretary
No Bio Available
Dr. Jan Van Rooyen
Head & Group Executive of Healius Pathology
No Bio Available
Ms. Paula Bayliss
Group Executive of People & Culture
No Bio Available
Mr. John McKechnie
Advisor
No Bio Available
Dr. Phil Lucas
Chief Executive of Lumus Imaging
No Bio Available
Ian Mcphan
Chief Operating Officer of Healius Pathology
No Bio Available
Sharon Ng
Head of Group FP&A
No Bio Available
Mr. Arjun Narang
Group Executive of Operations Transformation
No Bio Available
Mr. Jon Eide
Group Executive of Commercial & Customer
No Bio Available

Contacts

Address
NEW SOUTH WALES
Sydney
L 6 203 Pacific Hwy, St Leonards
Contacts
+61294329400.0
www.healius.com.au
sparklesyt

See Also

Summary
HLS intrinsic value, competitors valuation, and company profile.
DCF Valuation
HLS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HLS stock valuation using valuation multiples.
Wall Street Estimates
HLS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HLS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 212,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.